These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22777686)

  • 1. Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and in vivo bioavailability.
    Miller MA; Khan TA; Kaczorowski KJ; Wilson BK; Dinin AK; Borwankar AU; Rodrigues MA; Truskett TM; Johnston KP; Maynard JA
    J Pharm Sci; 2012 Oct; 101(10):3763-78. PubMed ID: 22777686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.
    Liu J; Nguyen MD; Andya JD; Shire SJ
    J Pharm Sci; 2005 Sep; 94(9):1928-40. PubMed ID: 16052543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrated dispersions of equilibrium protein nanoclusters that reversibly dissociate into active monomers.
    Johnston KP; Maynard JA; Truskett TM; Borwankar AU; Miller MA; Wilson BK; Dinin AK; Khan TA; Kaczorowski KJ
    ACS Nano; 2012 Feb; 6(2):1357-69. PubMed ID: 22260218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bulky Polar Additives That Greatly Reduce the Viscosity of Concentrated Solutions of Therapeutic Monoclonal Antibodies.
    Larson AM; Weight AK; Love K; Bonificio A; Wescott CR; Klibanov AM
    J Pharm Sci; 2017 May; 106(5):1211-1217. PubMed ID: 28137697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving Viscosity and Stability of a Highly Concentrated Monoclonal Antibody Solution with Concentrated Proline.
    Hung JJ; Dear BJ; Dinin AK; Borwankar AU; Mehta SK; Truskett TT; Johnston KP
    Pharm Res; 2018 Apr; 35(7):133. PubMed ID: 29713822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermolecular Interactions and the Viscosity of Highly Concentrated Monoclonal Antibody Solutions.
    Binabaji E; Ma J; Zydney AL
    Pharm Res; 2015 Sep; 32(9):3102-9. PubMed ID: 25832501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Approach to Mitigate Particle Formation on the Dilution of a Monoclonal Antibody Drug Product in an IV Administration Fluid.
    Zheng S; Adams M; Mantri RV
    J Pharm Sci; 2016 Mar; 105(3):1349-50. PubMed ID: 26886343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation.
    Salinas BA; Sathish HA; Bishop SM; Harn N; Carpenter JF; Randolph TW
    J Pharm Sci; 2010 Jan; 99(1):82-93. PubMed ID: 19475558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies.
    Wang S; Zhang N; Hu T; Dai W; Feng X; Zhang X; Qian F
    Mol Pharm; 2015 Dec; 12(12):4478-87. PubMed ID: 26528726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of stirring-induced microparticle formation in monoclonal antibody solutions.
    Ishikawa T; Kobayashi N; Osawa C; Sawa E; Wakamatsu K
    Biol Pharm Bull; 2010; 33(6):1043-6. PubMed ID: 20522974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Flexibility of Antibodies Preserved Even in the Dense Phase after Macroscopic Phase Separation.
    Girelli A; Beck C; Bäuerle F; Matsarskaia O; Maier R; Zhang F; Wu B; Lang C; Czakkel O; Seydel T; Schreiber F; Roosen-Runge F
    Mol Pharm; 2021 Nov; 18(11):4162-4169. PubMed ID: 34637319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing monoclonal antibody formulations in arginine glutamate solutions using
    Kheddo P; Cliff MJ; Uddin S; van der Walle CF; Golovanov AP
    MAbs; 2016 Oct; 8(7):1245-1258. PubMed ID: 27589351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
    Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystalline monoclonal antibodies for subcutaneous delivery.
    Yang MX; Shenoy B; Disttler M; Patel R; McGrath M; Pechenov S; Margolin AL
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):6934-9. PubMed ID: 12782786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro- and macro-viscosity relations in high concentration antibody solutions.
    Shah M; Corbett D; Lanzaro A; Roche A; Sibanda N; Davis P; Uddin S; van der Walle CF; Curtis R; Pluen A
    Eur J Pharm Biopharm; 2020 Aug; 153():211-221. PubMed ID: 32574706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid analysis of antibody self-association in complex mixtures using immunogold conjugates.
    Sule SV; Dickinson CD; Lu J; Chow CK; Tessier PM
    Mol Pharm; 2013 Apr; 10(4):1322-31. PubMed ID: 23383873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of a high-concentration monoclonal antibody solution produced by liquid-liquid phase separation.
    Bramham JE; Davies SA; Podmore A; Golovanov AP
    MAbs; 2021; 13(1):1940666. PubMed ID: 34225583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
    Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
    MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies.
    Guo Z; Chen A; Nassar RA; Helk B; Mueller C; Tang Y; Gupta K; Klibanov AM
    Pharm Res; 2012 Nov; 29(11):3102-9. PubMed ID: 22692671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.